Biblio
Found 2 results
Filters: Author is Wang, Steven [Clear All Filters]
.
2023. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.
.
2019. Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.. Head Neck. 41(12):4076-4087.